ID   KCNA1_RAT               Reviewed;         495 AA.
AC   P10499;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   24-JUL-2024, entry version 198.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 1 {ECO:0000305};
DE   AltName: Full=RBKI {ECO:0000303|PubMed:2539643};
DE   AltName: Full=RCK1 {ECO:0000303|PubMed:2348860, ECO:0000303|PubMed:8038169};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.1;
GN   Name=Kcna1 {ECO:0000312|RGD:2949};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=3191911; DOI=10.1002/j.1460-2075.1988.tb03092.x;
RA   Baumann A., Grupe A., Ackermann A., Pongs O.;
RT   "Structure of the voltage-dependent potassium channel is highly conserved
RT   from Drosophila to vertebrate central nervous systems.";
RL   EMBO J. 7:2457-2463(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR
RP   LOCATION, AND ACTIVITY REGULATION.
RC   TISSUE=Brain;
RX   PubMed=2539643; DOI=10.1126/science.2539643;
RA   Christie M.J., Adelman J.P., Douglass J., North R.A.;
RT   "Expression of a cloned rat brain potassium channel in Xenopus oocytes.";
RL   Science 244:221-224(1989).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND ACTIVITY
RP   REGULATION.
RX   PubMed=2348860; DOI=10.1038/345535a0;
RA   Ruppersberg J.P., Schroeter K.H., Sakmann B., Stocker M., Sewing S.,
RA   Pongs O.;
RT   "Heteromultimeric channels formed by rat brain potassium-channel
RT   proteins.";
RL   Nature 345:535-537(1990).
RN   [4]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, GLYCOSYLATION,
RP   PHOSPHORYLATION AT SER-446, AND MUTAGENESIS OF ARG-443 AND SER-446.
RX   PubMed=8038169; DOI=10.1021/bi00195a021;
RA   Ivanina T., Perets T., Thornhill W.B., Levin G., Dascal N., Lotan I.;
RT   "Phosphorylation by protein kinase A of RCK1 K+ channels expressed in
RT   Xenopus oocytes.";
RL   Biochemistry 33:8786-8792(1994).
RN   [5]
RP   RNA EDITING OF POSITION 400.
RX   PubMed=12907802; DOI=10.1126/science.1086763;
RA   Hoopengardner B., Bhalla T., Staber C., Reenan R.;
RT   "Nervous system targets of RNA editing identified by comparative
RT   genomics.";
RL   Science 301:832-836(2003).
RN   [6]
RP   INTERACTION WITH KCNAB1 AND KCNAB2, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9334400; DOI=10.1523/jneurosci.17-21-08246.1997;
RA   Rhodes K.J., Strassle B.W., Monaghan M.M., Bekele-Arcuri Z., Matos M.F.,
RA   Trimmer J.S.;
RT   "Association and colocalization of the Kvbeta1 and Kvbeta2 beta-subunits
RT   with Kv1 alpha-subunits in mammalian brain K+ channel complexes.";
RL   J. Neurosci. 17:8246-8258(1997).
RN   [7]
RP   SUBUNIT, INTERACTION WITH KCNA2 AND KCNA4, SUBCELLULAR LOCATION, AND
RP   GLYCOSYLATION.
RX   PubMed=10896669; DOI=10.1074/jbc.m005010200;
RA   Manganas L.N., Trimmer J.S.;
RT   "Subunit composition determines Kv1 potassium channel surface expression.";
RL   J. Biol. Chem. 275:29685-29693(2000).
RN   [8]
RP   INTERACTION WITH KCNA2 AND KCNA4, SUBUNIT, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11086297;
RX   DOI=10.1002/1096-9861(20000101)429:1<166::aid-cne13>3.0.co;2-y;
RA   Rasband M.N., Trimmer J.S.;
RT   "Subunit composition and novel localization of K+ channels in spinal
RT   cord.";
RL   J. Comp. Neurol. 429:166-176(2001).
RN   [9]
RP   INTERACTION WITH STX1A; GNB1 AND GNG2, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12114518; DOI=10.1074/jbc.m203943200;
RA   Michaelevski I., Chikvashvili D., Tsuk S., Fili O., Lohse M.J.,
RA   Singer-Lahat D., Lotan I.;
RT   "Modulation of a brain voltage-gated K+ channel by syntaxin 1A requires the
RT   physical interaction of Gbetagamma with the channel.";
RL   J. Biol. Chem. 277:34909-34917(2002).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12177193; DOI=10.1523/jneurosci.22-16-06953.2002;
RA   Dodson P.D., Barker M.C., Forsythe I.D.;
RT   "Two heteromeric Kv1 potassium channels differentially regulate action
RT   potential firing.";
RL   J. Neurosci. 22:6953-6961(2002).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12777451; DOI=10.1113/jphysiol.2003.046250;
RA   Dodson P.D., Billups B., Rusznak Z., Szucs G., Barker M.C., Forsythe I.D.;
RT   "Presynaptic rat Kv1.2 channels suppress synaptic terminal
RT   hyperexcitability following action potential invasion.";
RL   J. Physiol. (Lond.) 550:27-33(2003).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=12681381; DOI=10.1016/s0028-3908(03)00070-4;
RA   Winklhofer M., Matthias K., Seifert G., Stocker M., Sewing S., Herget T.,
RA   Steinhaeuser C., Saaler-Reinhardt S.;
RT   "Analysis of phosphorylation-dependent modulation of Kv1.1 potassium
RT   channels.";
RL   Neuropharmacology 44:829-842(2003).
RN   [13]
RP   INTERACTION WITH DLG1; DLG2 AND DLG4.
RX   PubMed=7477295; DOI=10.1038/378085a0;
RA   Kim E., Niethammer M., Rothschild A., Jan Y.N., Sheng M.;
RT   "Clustering of Shaker-type K+ channels by interaction with a family of
RT   membrane-associated guanylate kinases.";
RL   Nature 378:85-88(1995).
RN   [14]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16306173; DOI=10.1152/jn.01004.2005;
RA   Finnegan T.F., Chen S.R., Pan H.L.;
RT   "Mu opioid receptor activation inhibits GABAergic inputs to basolateral
RT   amygdala neurons through Kv1.1/1.2 channels.";
RL   J. Neurophysiol. 95:2032-2041(2006).
RN   [15]
RP   INTERACTION WITH LGI1; KCNA4 AND KCNAB1.
RX   PubMed=16504945; DOI=10.1016/j.neuron.2006.01.033;
RA   Schulte U., Thumfart J.-O., Kloecker N., Sailer C.A., Bildl W.,
RA   Biniossek M., Dehn D., Deller T., Eble S., Abbass K., Wangler T.,
RA   Knaus H.-G., Fakler B.;
RT   "The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels
RT   and inhibits inactivation by Kvbeta1.";
RL   Neuron 49:697-706(2006).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17855588; DOI=10.1152/jn.00437.2007;
RA   Chi X.X., Nicol G.D.;
RT   "Manipulation of the potassium channel Kv1.1 and its effect on neuronal
RT   excitability in rat sensory neurons.";
RL   J. Neurophysiol. 98:2683-2692(2007).
RN   [17]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17869444; DOI=10.1016/j.neuroscience.2007.08.007;
RA   Yang Q., Chen S.R., Li D.P., Pan H.L.;
RT   "Kv1.1/1.2 channels are downstream effectors of nitric oxide on synaptic
RT   GABA release to preautonomic neurons in the paraventricular nucleus.";
RL   Neuroscience 149:315-327(2007).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ACTIVITY REGULATION.
RX   PubMed=20805574; DOI=10.1085/jgp.200910398;
RA   Al-Sabi A., Shamotienko O., Dhochartaigh S.N., Muniyappa N., Le Berre M.,
RA   Shaban H., Wang J., Sack J.T., Dolly J.O.;
RT   "Arrangement of Kv1 alpha subunits dictates sensitivity to
RT   tetraethylammonium.";
RL   J. Gen. Physiol. 136:273-282(2010).
RN   [20]
RP   TISSUE SPECIFICITY.
RX   PubMed=21483673; DOI=10.1371/journal.pone.0018213;
RA   Ma Z., Lavebratt C., Almgren M., Portwood N., Forsberg L.E., Branstrom R.,
RA   Berglund E., Falkmer S., Sundler F., Wierup N., Bjorklund A.;
RT   "Evidence for presence and functional effects of Kv1.1 channels in beta-
RT   cells: general survey and results from mceph/mceph mice.";
RL   PLoS ONE 6:E18213-E18213(2011).
RN   [21]
RP   FUNCTION, TRANSPORTER ACTIVITY, MUTAGENESIS OF SER-309, SUBCELLULAR
RP   LOCATION, AND MISCELLANEOUS.
RX   PubMed=22206926; DOI=10.1016/j.brainres.2011.11.023;
RA   Ishida S., Sakamoto Y., Nishio T., Baulac S., Kuwamura M., Ohno Y.,
RA   Takizawa A., Kaneko S., Serikawa T., Mashimo T.;
RT   "Kcna1-mutant rats dominantly display myokymia, neuromyotonia and
RT   spontaneous epileptic seizures.";
RL   Brain Res. 1435:154-166(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-437 AND SER-439, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [23]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND ACTIVITY
RP   REGULATION.
RX   PubMed=23725331; DOI=10.1042/bj20130297;
RA   Al-Sabi A., Kaza S.K., Dolly J.O., Wang J.;
RT   "Pharmacological characteristics of Kv1.1- and Kv1.2-containing channels
RT   are influenced by the stoichiometry and positioning of their alpha
RT   subunits.";
RL   Biochem. J. 454:101-108(2013).
RN   [24]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND IDENTIFICATION IN A COMPLEX
RP   WITH KCNA2 AND KCNAB2.
RX   PubMed=23318870; DOI=10.1113/jphysiol.2012.249706;
RA   Ovsepian S.V., Steuber V., Le Berre M., O'Hara L., O'Leary V.B.,
RA   Dolly J.O.;
RT   "A defined heteromeric KV1 channel stabilizes the intrinsic pacemaking and
RT   regulates the output of deep cerebellar nuclear neurons to thalamic
RT   targets.";
RL   J. Physiol. (Lond.) 591:1771-1791(2013).
RN   [25]
RP   MUTAGENESIS OF ALA-352; HIS-355; SER-357; TYR-379 AND VAL-381.
RX   PubMed=25514171; DOI=10.1016/j.bcp.2014.12.002;
RA   Wang X., Umetsu Y., Gao B., Ohki S., Zhu S.;
RT   "Mesomartoxin, a new K(v)1.2-selective scorpion toxin interacting with the
RT   channel selectivity filter.";
RL   Biochem. Pharmacol. 93:232-239(2015).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 29-128, INTERACTION WITH KCNAB2,
RP   TETRAMERIZATION, SUBUNIT, AND DOMAIN.
RX   PubMed=10884227; DOI=10.1126/science.289.5476.123;
RA   Gulbis J.M., Zhou M., Mann S., MacKinnon R.;
RT   "Structure of the cytoplasmic beta subunit-T1 assembly of voltage-dependent
RT   K+ channels.";
RL   Science 289:123-127(2000).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates transmembrane
CC       potassium transport in excitable membranes, primarily in the brain and
CC       the central nervous system, but also in the kidney. Contributes to the
CC       regulation of the membrane potential and nerve signaling, and prevents
CC       neuronal hyperexcitability (PubMed:12177193, PubMed:17855588,
CC       PubMed:22206926). Forms tetrameric potassium-selective channels through
CC       which potassium ions pass in accordance with their electrochemical
CC       gradient (PubMed:23725331). The channel alternates between opened and
CC       closed conformations in response to the voltage difference across the
CC       membrane (PubMed:2539643). Can form functional homotetrameric channels
CC       and heterotetrameric channels that contain variable proportions of
CC       KCNA1, KCNA2, KCNA4, KCNA5, KCNA6, KCNA7, and possibly other family
CC       members as well; channel properties depend on the type of alpha
CC       subunits that are part of the channel (PubMed:10896669,
CC       PubMed:12177193, PubMed:2348860, PubMed:23725331). Channel properties
CC       are modulated by cytoplasmic beta subunits that regulate the
CC       subcellular location of the alpha subunits and promote rapid
CC       inactivation of delayed rectifier potassium channels (PubMed:10896669,
CC       PubMed:12114518). In vivo, membranes probably contain a mixture of
CC       heteromeric potassium channel complexes, making it difficult to assign
CC       currents observed in intact tissues to any particular potassium channel
CC       family member. Homotetrameric KCNA1 forms a delayed-rectifier potassium
CC       channel that opens in response to membrane depolarization, followed by
CC       slow spontaneous channel closure (PubMed:12681381, PubMed:22206926,
CC       PubMed:2348860, PubMed:23725331, PubMed:8038169). In contrast, a
CC       heterotetrameric channel formed by KCNA1 and KCNA4 shows rapid
CC       inactivation (PubMed:2348860). Regulates neuronal excitability in
CC       hippocampus, especially in mossy fibers and medial perforant path
CC       axons, preventing neuronal hyperexcitability. Response to toxins that
CC       are selective for KCNA1, respectively for KCNA2, suggests that
CC       heteromeric potassium channels composed of both KCNA1 and KCNA2 play a
CC       role in pacemaking and regulate the output of deep cerebellar nuclear
CC       neurons (PubMed:12177193, PubMed:23318870). May function as down-stream
CC       effector for G protein-coupled receptors and inhibit GABAergic inputs
CC       to basolateral amygdala neurons (PubMed:16306173). May contribute to
CC       the regulation of neurotransmitter release, such as gamma-aminobutyric
CC       acid (GABA) release (PubMed:17869444). Plays a role in regulating the
CC       generation of action potentials and preventing hyperexcitability in
CC       myelinated axons of the vagus nerve, and thereby contributes to the
CC       regulation of heart contraction (By similarity). Required for normal
CC       neuromuscular responses (PubMed:22206926). Regulates the frequency of
CC       neuronal action potential firing in response to mechanical stimuli, and
CC       plays a role in the perception of pain caused by mechanical stimuli,
CC       but does not play a role in the perception of pain due to heat stimuli
CC       (By similarity). Required for normal responses to auditory stimuli and
CC       precise location of sound sources, but not for sound perception (By
CC       similarity). The use of toxins that block specific channels suggest
CC       that it contributes to the regulation of the axonal release of the
CC       neurotransmitter dopamine (By similarity). Required for normal
CC       postnatal brain development and normal proliferation of neuronal
CC       precursor cells in the brain (By similarity). Plays a role in the
CC       reabsorption of Mg(2+) in the distal convoluted tubules in the kidney
CC       and in magnesium ion homeostasis, probably via its effect on the
CC       membrane potential (By similarity). {ECO:0000250|UniProtKB:P16388,
CC       ECO:0000250|UniProtKB:Q09470, ECO:0000269|PubMed:10896669,
CC       ECO:0000269|PubMed:12114518, ECO:0000269|PubMed:12177193,
CC       ECO:0000269|PubMed:12681381, ECO:0000269|PubMed:17855588,
CC       ECO:0000269|PubMed:17869444, ECO:0000269|PubMed:22206926,
CC       ECO:0000269|PubMed:23318870, ECO:0000269|PubMed:2348860,
CC       ECO:0000269|PubMed:23725331, ECO:0000269|PubMed:2539643,
CC       ECO:0000269|PubMed:8038169, ECO:0000305|PubMed:16306173}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:22206926, ECO:0000269|PubMed:2348860,
CC         ECO:0000269|PubMed:23725331, ECO:0000269|PubMed:2539643,
CC         ECO:0000269|PubMed:8038169};
CC   -!- ACTIVITY REGULATION: Inhibited by 4-aminopyridine (4-AP) and by
CC       tetraethylammonium (TEA) (PubMed:2539643). Inhibited by kaliotoxin
CC       (KTX) (PubMed:23725331). {ECO:0000269|PubMed:2348860,
CC       ECO:0000269|PubMed:23725331, ECO:0000269|PubMed:2539643}.
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-forming
CC       alpha subunits, such as KCNA2, KCNA4, KCNA5, KCNA6 and KCNA7
CC       (PubMed:10884227, PubMed:10896669). Channel activity is regulated by
CC       interaction with the beta subunits KCNAB1 and KCNAB2 (PubMed:12114518,
CC       PubMed:9334400). Identified in a complex with KCNA2 and KCNAB2
CC       (PubMed:10884227, PubMed:10896669, PubMed:11086297, PubMed:23318870).
CC       Interacts (via C-terminus) with the PDZ domains of DLG1, DLG2 and DLG4.
CC       Interacts with LGI1 within a complex containing LGI1, KCNA4 and KCNAB1.
CC       Interacts (via cytoplasmic N-terminal domain) with KCNRG; this inhibits
CC       channel activity (By similarity). Interacts with ANK3; this inhibits
CC       channel activity (By similarity). Interacts (via N-terminus) with
CC       STX1A; this promotes channel inactivation (PubMed:12114518). Interacts
CC       (via N-terminus) with the heterodimer formed by GNB1 and GNG2; this
CC       promotes channel inactivation (PubMed:12114518). Can interact
CC       simultaneously with STX1A and the heterodimer formed by GNB1 and GNG2
CC       (PubMed:12114518). Interacts with ADAM11 (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P16388, ECO:0000250|UniProtKB:Q09470,
CC       ECO:0000269|PubMed:10884227, ECO:0000269|PubMed:10896669,
CC       ECO:0000269|PubMed:11086297, ECO:0000269|PubMed:12114518,
CC       ECO:0000269|PubMed:16504945, ECO:0000269|PubMed:23318870,
CC       ECO:0000269|PubMed:7477295, ECO:0000269|PubMed:9334400}.
CC   -!- INTERACTION:
CC       P10499; P78352: DLG4; Xeno; NbExp=2; IntAct=EBI-631463, EBI-80389;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12114518,
CC       ECO:0000269|PubMed:12681381, ECO:0000269|PubMed:17855588,
CC       ECO:0000269|PubMed:22206926, ECO:0000269|PubMed:2348860,
CC       ECO:0000269|PubMed:23725331, ECO:0000269|PubMed:2539643,
CC       ECO:0000269|PubMed:8038169}; Multi-pass membrane protein {ECO:0000305}.
CC       Membrane {ECO:0000269|PubMed:11086297, ECO:0000269|PubMed:9334400}.
CC       Cell projection, axon {ECO:0000269|PubMed:11086297,
CC       ECO:0000269|PubMed:12177193, ECO:0000269|PubMed:9334400}. Cytoplasmic
CC       vesicle {ECO:0000269|PubMed:12177193, ECO:0000269|PubMed:8038169}.
CC       Perikaryon {ECO:0000269|PubMed:12177193}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:10896669, ECO:0000269|PubMed:12681381}. Cell
CC       projection, dendrite {ECO:0000250|UniProtKB:P16388}. Cell junction
CC       {ECO:0000250|UniProtKB:P16388}. Synapse {ECO:0000250|UniProtKB:P16388}.
CC       Presynapse {ECO:0000250|UniProtKB:P16388}. Presynaptic cell membrane
CC       {ECO:0000269|PubMed:17869444}. Note=Homotetrameric KCNA1 is primarily
CC       located in the endoplasmic reticulum. Interaction with KCNA2 and KCNAB2
CC       or with KCNA4 and KCNAB2 promotes expression at the cell membrane
CC       (PubMed:10896669). {ECO:0000250|UniProtKB:P16388,
CC       ECO:0000269|PubMed:10896669}.
CC   -!- TISSUE SPECIFICITY: Detected in hippocampus, in the middle third of the
CC       molecular layer of the dentate gyrus and in stratum radiatum and
CC       stratum oriens (PubMed:9334400). Detected in the mossy fiber zone in
CC       the hippocampus CA3 region, at or near axon terminals (PubMed:9334400).
CC       Detected in brain cortex, at basket cell terminals (PubMed:9334400).
CC       Detected adjacent to nodes of Ranvier in juxtaparanodal zones in spinal
CC       cord nerve fibers, but also in paranodal regions in some myelinated
CC       spinal cord axons (PubMed:11086297). Detected in juxtaparanodal regions
CC       adjacent to the nodes of Ranvier in myelinated axons in cerebellar
CC       white matter (PubMed:9334400). Detected in sensory neurons
CC       (PubMed:17855588). Detected in neurons from the medial nucleus of the
CC       trapezoid body (PubMed:12177193). Detected in basolateral amygdala
CC       (PubMed:16306173). Detected in the paraventricular nucleus of the
CC       hypothalamus (PubMed:17869444). Detected in the islet of Langerhans (at
CC       protein level) (PubMed:21483673). {ECO:0000269|PubMed:11086297,
CC       ECO:0000269|PubMed:12177193, ECO:0000269|PubMed:16306173,
CC       ECO:0000269|PubMed:17855588, ECO:0000269|PubMed:21483673,
CC       ECO:0000269|PubMed:9334400}.
CC   -!- DOMAIN: The cytoplasmic N-terminus is important for tetramerization and
CC       for interaction with the beta subunits that promote rapid channel
CC       closure. {ECO:0000269|PubMed:10884227}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as a voltage-sensor and
CC       is characterized by a series of positively charged amino acids at every
CC       third position. Channel opening and closing is effected by a
CC       conformation change that affects the position and orientation of the
CC       voltage-sensor paddle formed by S3 and S4 within the membrane. A
CC       transmembrane electric field that is positive inside would push the
CC       positively charged S4 segment outwards, thereby opening the pore, while
CC       a field that is negative inside would pull the S4 segment inwards and
CC       close the pore. Changes in the position and orientation of S4 are then
CC       transmitted to the activation gate formed by the inner helix bundle via
CC       the S4-S5 linker region. {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Palmitoylated on Cys-243; which may be required for membrane
CC       targeting. {ECO:0000250|UniProtKB:Q09470}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10896669,
CC       ECO:0000269|PubMed:8038169}.
CC   -!- PTM: Phosphorylated on tyrosine residues. Phosphorylation increases in
CC       response to NRG1; this inhibits channel activity (By similarity).
CC       Phosphorylated by PKA (PubMed:12681381, PubMed:8038169).
CC       Phosphorylation at Ser-446 regulates channel activity by down-
CC       regulating expression at the cell membrane (By similarity).
CC       {ECO:0000250|UniProtKB:P16388, ECO:0000250|UniProtKB:Q09470,
CC       ECO:0000269|PubMed:12681381, ECO:0000269|PubMed:8038169}.
CC   -!- RNA EDITING: Modified_positions=400 {ECO:0000269|PubMed:12907802};
CC       Note=Partially edited. RNA editing is at an average of 50% in the whole
CC       brain.;
CC   -!- MISCELLANEOUS: A missense mutation at Ser-309 is the cause of the
CC       autosomal dominant myokymia and seizures (ADMS) phenotype. Homozygous
CC       and heterozygous rats are born at the expected Mendelian rate. After 6
CC       weeks, heterozygous rats begin to display muscle twitching, startle
CC       responses and spontaneous convulsive seizures; over 80% of the animals
CC       are dead after 30 weeks. After 16 weeks, they display lower body weight
CC       compared to wild-type. The rats exhibit severe periodic seizures with
CC       characteristic alterations in their cortical and hippocampal
CC       electroencephalogram, similar to rodent models of temporal lobe
CC       epilepsy. Homozygous rats display impaired development starting 14 days
CC       after birth, with reduced body weight, tremors, motor incoordination,
CC       spontaneous convulsive seizures; none survive past 18 days after birth.
CC       {ECO:0000269|PubMed:22206926}.
CC   -!- MISCELLANEOUS: The delay or D-type current observed in hippocampus
CC       pyramidal neurons is probably mediated by potassium channels containing
CC       KCNA2 plus KCNA1 or other family members. It is activated at about -50
CC       mV, i.e. below the action potential threshold, and is characterized by
CC       slow inactivation, extremely slow recovery from inactivation,
CC       sensitivity to dendrotoxin (DTX) and to 4-aminopyridine (4-AP).
CC       {ECO:0000305|PubMed:17917103}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker) (TC
CC       1.A.1.2) subfamily. Kv1.1/KCNA1 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X12589; CAA31102.1; -; mRNA.
DR   EMBL; M26161; AAA41982.1; -; mRNA.
DR   PIR; B39113; B39113.
DR   RefSeq; NP_775118.1; NM_173095.3.
DR   PDB; 1EXB; X-ray; 2.10 A; E=27-129.
DR   PDBsum; 1EXB; -.
DR   AlphaFoldDB; P10499; -.
DR   SMR; P10499; -.
DR   BioGRID; 246675; 4.
DR   CORUM; P10499; -.
DR   IntAct; P10499; 3.
DR   MINT; P10499; -.
DR   STRING; 10116.ENSRNOP00000026731; -.
DR   BindingDB; P10499; -.
DR   ChEMBL; CHEMBL5190; -.
DR   GuidetoPHARMACOLOGY; 538; -.
DR   GlyCosmos; P10499; 1 site, No reported glycans.
DR   GlyGen; P10499; 1 site.
DR   iPTMnet; P10499; -.
DR   PhosphoSitePlus; P10499; -.
DR   PaxDb; 10116-ENSRNOP00000026731; -.
DR   ABCD; P10499; 2 sequenced antibodies.
DR   Ensembl; ENSRNOT00000101523.1; ENSRNOP00000081659.1; ENSRNOG00000064052.1.
DR   Ensembl; ENSRNOT00055018095; ENSRNOP00055014537; ENSRNOG00055010711.
DR   Ensembl; ENSRNOT00060028402; ENSRNOP00060022866; ENSRNOG00060016588.
DR   Ensembl; ENSRNOT00065057508; ENSRNOP00065047349; ENSRNOG00065033451.
DR   GeneID; 24520; -.
DR   KEGG; rno:24520; -.
DR   UCSC; RGD:2949; rat.
DR   AGR; RGD:2949; -.
DR   CTD; 3736; -.
DR   RGD; 2949; Kcna1.
DR   eggNOG; KOG1545; Eukaryota.
DR   GeneTree; ENSGT00940000158576; -.
DR   HOGENOM; CLU_011722_4_0_1; -.
DR   InParanoid; P10499; -.
DR   OMA; IATQNCV; -.
DR   OrthoDB; 1478695at2759; -.
DR   PhylomeDB; P10499; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   EvolutionaryTrace; P10499; -.
DR   PRO; PR:P10499; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000019750; Expressed in cerebellum and 4 other cell types or tissues.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0043194; C:axon initial segment; ISO:RGD.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0044305; C:calyx of Held; IDA:SynGO.
DR   GO; GO:0030054; C:cell junction; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0044224; C:juxtaparanode region of axon; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0033270; C:paranode region of axon; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0034705; C:potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IMP:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:1905030; F:voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0099508; F:voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0001508; P:action potential; IBA:GO_Central.
DR   GO; GO:0061564; P:axon development; IEP:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0010644; P:cell communication by electrical coupling; IMP:UniProtKB.
DR   GO; GO:0071286; P:cellular response to magnesium ion; ISS:UniProtKB.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0022038; P:corpus callosum development; IEP:RGD.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0050976; P:detection of mechanical stimulus involved in sensory perception of touch; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; ISO:RGD.
DR   GO; GO:0010960; P:magnesium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0086011; P:membrane repolarization during action potential; IDA:UniProtKB.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0050905; P:neuromuscular process; ISS:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; IMP:UniProtKB.
DR   GO; GO:0023041; P:neuronal signal transduction; IMP:UniProtKB.
DR   GO; GO:0021554; P:optic nerve development; IEP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0008104; P:protein localization; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; ISS:UniProtKB.
DR   GO; GO:0006937; P:regulation of muscle contraction; IMP:UniProtKB.
DR   GO; GO:0001964; P:startle response; IMP:UniProtKB.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004048; K_chnl_volt-dep_Kv1.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537:SF24; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY A MEMBER 1; 1.
DR   PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01508; KV11CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Cytoplasmic vesicle; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Lipoprotein; Membrane; Palmitate; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; RNA editing;
KW   Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN           1..495
FT                   /note="Potassium voltage-gated channel subfamily A member
FT                   1"
FT                   /id="PRO_0000053970"
FT   TOPO_DOM        1..164
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        165..186
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        187..220
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        221..242
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        243..253
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        254..274
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        275..287
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        288..308
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        309..323
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        324..345
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        346..359
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   INTRAMEM        360..371
FT                   /note="Helical; Name=Pore helix"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   INTRAMEM        372..379
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        380..386
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TRANSMEM        387..415
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        416..495
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   REGION          1..128
FT                   /note="Tetramerization domain"
FT                   /evidence="ECO:0000305"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          310..323
FT                   /note="S4-S5 linker"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   MOTIF           372..377
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   MOTIF           493..495
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         322
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         437
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         439
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         446
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:8038169"
FT   LIPID           243
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q09470"
FT   CARBOHYD        207
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         400
FT                   /note="I -> V (in RNA edited version)"
FT   MUTAGEN         309
FT                   /note="S->T: In ADMS: Dominant negative mutation that
FT                   abolishes channel activity; leads to myokymia,
FT                   neuromyotonia, spontaneous epileptic seizures and premature
FT                   death."
FT                   /evidence="ECO:0000269|PubMed:22206926"
FT   MUTAGEN         352
FT                   /note="A->R: Is not blocked by the scorpion mesomartoxin."
FT                   /evidence="ECO:0000269|PubMed:25514171"
FT   MUTAGEN         355
FT                   /note="H->Q: Is not blocked by the scorpion mesomartoxin."
FT                   /evidence="ECO:0000269|PubMed:25514171"
FT   MUTAGEN         357
FT                   /note="S->P: Is not blocked by the scorpion mesomartoxin."
FT                   /evidence="ECO:0000269|PubMed:25514171"
FT   MUTAGEN         379
FT                   /note="Y->V: Is blocked by the scorpion mesomartoxin, with
FT                   an IC(50)=16.60 nM."
FT                   /evidence="ECO:0000269|PubMed:25514171"
FT   MUTAGEN         381
FT                   /note="V->T: Is not blocked by the scorpion mesomartoxin."
FT                   /evidence="ECO:0000269|PubMed:25514171"
FT   MUTAGEN         443
FT                   /note="R->C: Abolishes phosphorylation by PKA; when
FT                   associated with A-446."
FT   MUTAGEN         446
FT                   /note="S->A: Abolishes phosphorylation by PKA; when
FT                   associated with C-443."
FT   STRAND          38..43
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   STRAND          46..51
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   HELIX           52..56
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   TURN            62..64
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   HELIX           66..69
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   TURN            75..78
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   HELIX           86..97
FT                   /evidence="ECO:0007829|PDB:1EXB"
FT   HELIX           110..119
FT                   /evidence="ECO:0007829|PDB:1EXB"
SQ   SEQUENCE   495 AA;  56379 MW;  29804463133F5D31 CRC64;
     MTVMSGENAD EASAAPGHPQ DGSYPRQADH DDHECCERVV INISGLRFET QLKTLAQFPN
     TLLGNPKKRM RYFDPLRNEY FFDRNRPSFD AILYYYQSGG RLRRPVNVPL DMFSEEIKFY
     ELGEEAMEKF REDEGFIKEE ERPLPEKEYQ RQVWLLFEYP ESSGPARVIA IVSVMVILIS
     IVIFCLETLP ELKDDKDFTG TIHRIDNTTV IYTSNIFTDP FFIVETLCII WFSFELVVRF
     FACPSKTDFF KNIMNFIDIV AIIPYFITLG TEIAEQEGNQ KGEQATSLAI LRVIRLVRVF
     RIFKLSRHSK GLQILGQTLK ASMRELGLLI FFLFIGVILF SSAVYFAEAE EAESHFSSIP
     DAFWWAVVSM TTVGYGDMYP VTIGGKIVGS LCAIAGVLTI ALPVPVIVSN FNYFYHRETE
     GEEQAQLLHV SSPNLASDSD LSRRSSSTIS KSEYMEIEED MNNSIAHYRQ ANIRTGNCTA
     TDQNCVNKSK LLTDV
//
